IPO Calendar
Lead Manager
- J P Morgan Chase (515)
- Goldman Sachs (492)
- Morgan Stanley (445)
- Bank of America Merrill Lynch (374)
- Citigroup (236)
- Jefferies (223)
- Credit Suisse (180)
- Barclays (158)
- Cowen and Company (147)
- Deutsche Bank (85)
- Leerink Partners (73)
- Piper Jaffray (70)
- Stifel (67)
- UBS Investment Bank (56)
- Evercore (55)
- RBC Capital (53)
- BMO Capital (52)
- Wells Fargo (48)
- Piper Sandler (43)
- Revere Securities (42)
More +
Latest IPOs (70)
| UnderWriters | |||||||||||
| Date | Company Name | Ticker | Sector | Price ($) |
Size (M) |
1 | 2 | 3 | Rank | Turnover | Gain |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 8 | Bellicum Pharmaceuticals Inc. | BLCM | Health-Care | 19 | 7 | CITI | JEFF | PPRJ | 129.4% | 25.7% | |
| Feb 8 | Boot Barn Holdings Inc. | BOOT | Consumer-Services | 16 | 5 | JPM | JEFF | PPRJ | 137.7% | 9.1% | |
| Feb 8 | Sientra Inc. | SIEN | Health-Care | 15 | 5 | PPRJ | Stifel | 75.2% | 11.7% | ||
| Feb 8 | Dave & Buster`s Entertainment Inc. | PLAY | Consumer-Services | 16 | 5 | JEFF | PPRJ | 119.8% | 7.7% | ||
| Feb 8 | CareDx Inc. | CDNA | Health-Care | 10 | 4 | LRNK | PPRJ | 39.9% | -9.5% | ||
| Feb 8 | Amphastar Pharmaceuticals Inc. | AMPH | Health-Care | 7 | 8 | BMO | JEFF | PPRJ | 52% | 25% | |
| Feb 8 | Materialise NV | MTLS | Technology | 12 | 8 | CS | PPRJ | 75.9% | -3.7% | ||
| Feb 8 | Eagle Pharmaceuticals Inc. | EGRX | Health-Care | 15 | 3 | PPRJ | WB | 177.3% | -14.5% | ||
| Feb 8 | Revance Therapeutics Inc. | RVNC | Health-Care | 16 | 6 | COWN | PPRJ | 84% | 67.8% | ||
| Feb 8 | Cara Therapeutics Inc. | CARA | Health-Care | 11 | 5 | PPRJ | Stifel | 40.3% | 17.4% | ||
| Feb 8 | Voyager Therapeutics Inc. | VYGR | Health-Care | 14 | 5 | COWN | PPRJ | 25.2% | 26.8% | ||
| Feb 8 | REGENXBIO Inc. | RGNX | Health-Care | 22 | 6 | BAML | MS | PPRJ | 57.1% | 38.4% | |
| Feb 8 | Zynerba Pharmaceuticals Inc. | ZYNE | Health-Care | 14 | 3 | JEFF | PPRJ | 51.2% | 16.1% | ||
| Feb 8 | vTv Therapeutics Inc. | VTVT | Health-Care | 15 | 7 | PPRJ | Stifel | 64.2% | -27.4% | ||
| Feb 8 | Natera Inc. | NTRA | Health-Care | 18 | 10 | COWN | MS | PPRJ | 136.6% | 26.3% | |
| Feb 8 | Celyad SA | CYAD | Health-Care | 68.6 | 1 | PPRJ | UBS | 61.2% | -20.4% | ||
| Feb 8 | Arcadia Biosciences Inc. | RKDA | Basic-Industries | 8 | 8 | CS | JPM | PPRJ | 1% | 1725% | |
| Feb 8 | Collegium Pharmaceutical Inc. | COLL | Health-Care | 12 | 5 | JEFF | PPRJ | 24.2% | 2.4% | ||
| Feb 8 | Cellectis S.A. | CLLS | Health-Care | 41.5 | 5 | BAML | JEFF | PPRJ | 76.1% | -5.3% | |
| Feb 8 | CRISPR Therapeutics AG | CRSP | Health-Care | 14 | 4 | BRCL | CITI | PPRJ | 47.1% | 0.6% | |
| Feb 8 | Fulgent Genetics Inc. | FLGT | Health-Care | 9 | 4 | CS | PPRJ | 57.4% | 2% | ||
| Feb 8 | Novan Inc. | NOVN | Health-Care | 11 | 4 | PPRJ | 45.7% | 64.5% | |||
| Feb 8 | Tactile Systems Technology Inc. | TCMD | Health-Care | 10 | 4 | CNCD | PPRJ | WB | 39.2% | 10.8% | |
| Feb 8 | Impinj Inc. | PI | Capital-Goods | 14 | 4 | PPRJ | RBC | 98.9% | 28.4% | ||
| Feb 8 | Syros Pharmaceuticals Inc. | SYRS | Health-Care | 12.5 | 4 | COWN | PPRJ | 22% | 45.2% | ||
| Feb 8 | OptiNose Inc. | OPTN | Health-Care | 16 | 7 | JEFF | PPRJ | BMO | 52.2% | 18.8% | |
| Feb 8 | OrthoPediatrics Corp. | KIDS | Health-Care | 13 | 4 | PPRJ | Stifel | 72.1% | 51.7% | ||
| Feb 8 | Deciphera Pharmaceuticals Inc. | DCPH | Health-Care | 17 | 7 | JPM | PPRJ | 77.2% | 3.8% | ||
| Feb 8 | Biohaven Pharmaceutical Holding Company Ltd. | BHVN | Health-Care | 17 | 9 | MS | PPRJ | BRCL | 39.8% | 2.9% | |
| Feb 8 | Ra Medical Systems Inc. | RMED | Health-Care | 17 | 3 | CNTR | PPRJ | 60.6% | 17.6% | ||
| Feb 8 | Sutro Biopharma Inc. | STRO | Health-Care | 15 | 5 | COWN | PPRJ | 47.7% | 1.3% | ||
| Feb 8 | Arvinas Inc. | ARVN | Health-Care | 16 | 7 | CITI | GS | PPRJ | 45.6% | 0.3% | |
| Feb 8 | Crinetics Pharmaceuticals Inc. | CRNX | Health-Care | 17 | 6 | JPM | LRNK | PPRJ | 60% | 44.2% | |
| Feb 8 | Neuronetics Inc. | STIM | Health-Care | 17 | 5 | PPRJ | WB | 45.5% | 63.4% | ||
| Feb 8 | electroCore Inc. | ECOR | Health-Care | 15 | 5 | EVCR | JMPS | PPRJ | 35.2% | 32.3% | |
| Feb 8 | ASLAN Pharmaceuticals Limited | ASLN | Health-Care | 7 | 6 | LRNK | PPRJ | 13.6% | -20.2% | ||
| Feb 8 | Motus GI Holdings Inc. | MOTS | Health-Care | 5 | 3 | OPPN | PPRJ | 18.6% | -12.4% | ||
| Feb 8 | Tandem Diabetes Care Inc | TNDM | Health-Care | 15 | 8 | BAML | PPRJ | 5% | 1184% | ||
| Feb 8 | voxeljet AG | VJET | Capital-Goods | 13 | 6 | CITI | PPRJ | 189.4% | 121.5% | ||
| Feb 8 | Applied Optoelectronics Inc | AAOI | Technology | 10 | 3 | PPRJ | RAYJ | 26.4% | -0.4% | ||
| Feb 8 | Fox Factory Holding Corp | FOXF | Consumer-Non-Durables | 15 | 8 | PPRJ | RWB | WB | 74.3% | 24.1% | |
| Feb 8 | Marrone Bio Innovations Inc | MBII | Basic-Industries | 12 | 4 | JEFF | PPRJ | 20.7% | 14.6% | ||
| Feb 8 | Globus Medical Inc | GMED | Health-Care | 12 | 8 | BAML | GS | PPRJ | 46.8% | 12.5% | |
| Feb 8 | Natural Grocers by Vitamin Cottage Inc | NGVC | Consumer-Services | 15 | 7 | PPRJ | SNTR | 88% | 19.1% | ||
| Feb 8 | Tilly s Inc | TLYS | NA | 15.5 | 8 | BAML | GS | PPRJ | 115.2% | 8.5% | |
| Feb 8 | Supernus Pharmaceuticals Inc | SUPN | Health-Care | 5 | 10 | CITI | PPRJ | 6.8% | 7.4% | ||
| Feb 8 | Proto Labs Inc | PRLB | Capital-Goods | 16 | 4 | JEFF | PPRJ | 94% | 81.3% | ||
| Jul 20 | Turnstone Biologics Corp. | TSBX | Health Care | 12 | 6 | BAML | LRNK | PPRJ | 17.2% | -8.3% | |
| May 8 | NextCure Inc. | NXTC | NA | 15 | 5 | MS | BAML | PPRJ | 32.9% | 32.7% | |
| May 8 | Milestone Pharmaceuticals Inc. | MIST | NA | 15 | 5 | JEFF | COWN | PPRJ | 17.9% | 2.5% | |
| May 22 | Bicycle Therapeutics Limited | BCYC | NA | 14 | 4 | GS | JEFF | PPRJ | 22.8% | -14.3% | |
| Sep 17 | IGM Biosciences Inc. | IGMS | Health-Care | 16 | 10 | JEFF | PPRJ | Stifel | 16% | 51.9% | |
| Oct 30 | Oyster Point Pharma Inc. | OYST | Health-Care | 16 | 5 | JPM | COWN | PPRJ | 20.4% | 17.4% | |
| Nov 7 | TELA Bio Inc. | TELA | Health-Care | 13 | 4 | JEFF | PPRJ | 31.8% | 2.7% | ||
| Jul 23 | Inozyme Pharma Inc. | INZY | Health-Care | 17 | 14 | BAML | COWN | PPRJ | 11.8% | 3.2% | |
| Aug 18 | Harmony Biosciences Holdings Inc. | HRMY | Health-Care | 37 | 24 | GS | JEFF | PPRJ | 2.4% | -2.5% | |
| Oct 1 | Oncorus Inc. | ONCR | Health-Care | 15 | 5 | JEFF | EVCR | PPRJ | 12.6% | 6.7% | |
| Sep 30 | Aziyo Biologics Inc. | AZYO | Health-Care | 17 | 2 | PPRJ | COWN | 70.5% | -14.7% | ||
| Oct 9 | Aligos Therapeutics Inc. | ALGS | Health-Care | 15 | 10 | JPM | JEFF | PPRJ | 27.6% | -1% | |
| Dec 2 | Kinnate BioPharma Inc. | KNTE | Health-Care | 20 | 12 | GS | LRNK | PPRJ | 5.3% | 117.3% | |
| Feb 3 | Sensei Biotherapeutics Inc. | SNSE | Health-Care | 19 | 7 | CITI | PPRJ | OPPN | 52.7% | -0.5% | |
| Feb 11 | Talis Biomedical Corporation | TLIS | Health-Care | 16 | 13 | JPM | BAML | PPRJ | 22.8% | 73.8% | |
| Mar 3 | Khosla Ventures Acquisition Co. | KVSA | Finance | 10 | 30 | GS | PPRJ | 28.1% | 2.5% | ||
| Mar 18 | Connect Biopharma Holdings Ltd. | CNTB | Health-Care | 17 | 11 | JEFF | PPRJ | CICC | 28.4% | 8.8% | |
| Jul 22 | Cytek BioSciences Inc. | CTKB | Health-Care | 17 | 16 | MS | GS | PPRJ | 18.9% | 10.4% | |
| Jul 28 | Nuvalent Inc. | NUVL | Health-Care | 17 | 9 | JPM | COWN | PPRJ | 23.9% | 10.3% | |
| Oct 14 | Paragon 28 Inc. | FNA | Health-Care | 16 | 7 | BAML | PPRJ | 55.7% | 13.6% | ||
| Oct 19 | Ventyx Biosciences Inc. | VTYX | Health-Care | 16 | 9 | JEFF | EVCR | PPRJ | 17.9% | 31.4% | |
| Feb 4 | Silver Spike Investment Corp. | SSIC | Finance | 14 | 6 | Stifel | PPRJ | 4.3% | 0% | ||
| May 4 | Hanover Bancorp, Inc./NY | HNVR | Finance | 21 | 1 | STPH | PPRJ | 31.6% | 0.5% | ||